F-star Therapeutics CEO Eliot Forster's 2020 pay jumps 193% to $4.5M

F-star Therapeutics reports 2020 executive compensation

By ExecPay News

Published: April 7, 2021

F-star Therapeutics reported fiscal year 2020 executive compensation information on April 7, 2021.
In 2020, seven executives at F-star Therapeutics received on average a compensation package of $1.4M, a 43% increase compared to previous year.
Average pay of disclosed executives at F-star Therapeutics
Eliot Forster, Chief Executive Officer, received $4.5M in total, which increased by 193% compared to 2019. 77% of Forster's compensation, or $3.5M, was in option awards. Forster also received $402K in bonus, $645K in salary, as well as $1.9K in other compensation.
Neil Brewis, Chief Scientific Officer, received a compensation package of $1.7M, which increased by 234% compared to previous year. 64% of the compensation package, or $1.1M, was in option awards.
Louis Kayitalire, Chief Medical Officer, earned $1M in 2020, a 39% increase compared to previous year.
Darlene Deptula-Hicks, Chief Financial Officer, received $983K in 2020, which increases by 13% compared to 2019.
R.P. “Kris” Iyer, Chief Scientific Officer, earned $842K in 2020, a 5% decrease compared to previous year.
Martin Driscoll, Chief Executive Officer, received $688K in 2020, which decreases by 52% compared to 2019.
Jonathan Freve, Chief Financial Officer, earned $230K in 2020, a 77% decrease compared to previous year.

Related executives

Eliot Forster

F-star Therapeutics

Chief Executive Officer

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

Louis Kayitalire

F-star Therapeutics

Chief Medical Officer

Neil Brewis

F-star Therapeutics

Chief Scientific Officer

RP Iyer

F-star Therapeutics

Chief Scientific Officer

Martin Driscoll

F-star Therapeutics

Chief Executive Officer

Jonathan Freve

F-star Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on April 7, 2021.